NDC 61958-2501 – Biktarvy
Bictegravir Sodium 50 mg/1; Emtricitabine 200 mg/1; Tenofovir Alafenamide Fumarate 25 mg/1 · Tablet · Oral
Product NDC61958-2501
Product details
- Brand name
- Biktarvy
- Generic name
- Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA210251
- Marketed since
- February 7, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Bictegravir Sodium 50 mg/1
- Emtricitabine 200 mg/1
- Tenofovir Alafenamide Fumarate 25 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 61958-2501-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1) | Feb 7, 2018 |
| 61958-2501-2 | 7 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2) | Jul 26, 2018 |
| 61958-2501-3 | 30 TABLET in 1 BLISTER PACK (61958-2501-3) | Aug 24, 2021 |
| 61958-2501-5 | 30 TABLET in 1 BLISTER PACK (61958-2501-5) | Mar 30, 2026 |
Other Biktarvy products
- 50090-6247 Bictegravir Sodium 50 mg/1; Emtricitabine 200 mg/1; Tenofovir… · Tablet · A-S Medication Solutions
- 61958-2505 Bictegravir Sodium 30 mg/1; Emtricitabine 120 mg/1; Tenofovir… · Tablet · Gilead Sciences, Inc.
- 61958-2506 Bictegravir Sodium 30 mg/1; Emtricitabine 120 mg/1; Tenofovir… · Tablet · Gilead Sciences, Inc.